The Comparison of Dose Distribution on Radiation Therapy between IMRT and VMAT in Modified Radical Mastectomy Patients

전유방절제술 환자에서 IMRT와 VMAT을 이용한 방사선치료시 선량 분포의 비교

  • 고혜진 (조선대학교병원 방사선종양학과) ;
  • 김영재 (대구보건대학교 방사선과) ;
  • 장성주 (동신대학교 방사선학과)
  • Received : 2014.04.29
  • Accepted : 2014.05.30
  • Published : 2014.08.28


Underwent on modified radical mastectomy(MRM) and radiation therapy, it affects increasing rates of chronic morbidity, because of including chest wall and internal mammary nodes(IMNs). It causes the high absorbed dose on heart and ipsilateral lung. Thus in this study, we compared dose distributions through utilizing the intensity modulated radiation therapy(IMRT) and the volumetric modulated arc therapy(VMAT). We selected 10 breast cancer patients at random who took MRM and radiation therapy. Treatment plannings were done by using IMRT and VMAT from each patient ranging supraclavicular lymphnodes(SCL) and IMNs. After that we analysed the planning target volume(PTV)'s conformity and absorbed doses on heart and lungs. As a results, PTV conformities were indicated the same patten(p<0.05) in both plans. In case of Lt breast cancer patients, the dose maximum regions of the heart were more lesser in VMAT technique rather than the IMRT(p<0.05). Also, the maximum dose areas of lungs were lesser in VMAT technique rather than the IMRT(p<0.05). Therefore, it would be safe to say that it is more effective way to adapt the VMAT technique than IMRT in such cases like involve IMNs in breast cancer patients.


Breast Cancer;Intensity Modulated Radiation Therapy;Volumetric Modulated Arc Therapy


  1. ICRU, International Commission on Radiation Units and Measurements, Report 62: Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50), 1999.
  2. G. Gyenes, L. E. Rutqvist, and A. Liedberg, "Long-term cardiac morbidity and mortality in a randomized trial of pre-and post operative radiation therapy versus surgery alone in pprimary breast cancer," Radiother Oncol, Vol.48, No.2, pp.185-190, 1998.
  3. B. A. Fraass, A. S. Lichter, and D. L. McShan DL, "The influence of lung density corrections on treatment planning for primary breast cancer," Int J Radiat Oncol Biol Phys, Vol.14, No.1, pp.179-190, 1988.
  4. Tomas Kron, Grigor Grigorov, and Edward Yu et al, "Planning evaluation of radiotherapy for complex lung cancer cases using helical tomotherapy," Phys Med Biol, Vol.49, No.16, pp.3675-3690, 2004.
  5. Carmen C. Popescu, Ivo Olivotto, and Veronica Patenaude, "Inverse-planned, dynamic, multi-beam, intensity-modulated radiation therapy (IMRT): A promising technique when target volume is the left breast and internal mammary lymph nodes," Medical Dosimetry, Vol.31, No.4, pp.283-291, 2004.
  6. Filip Claus, Wim Duthoya, and Tom Boterberga, "Intensity modulated radiation therapy for oropharyngeal and oral cavity tumors: clinical use and experience," Oral Oncology, Vol.38, No.6, pp.597-604, 2002.
  7. D. Palma, K. Otto, W. Verbakel, and S. Senan, "New Developments in Arc Radiation Therapy: A Review," Cancer Treatment Reviews, Vol.36, No.5, pp.393-399, 2010.
  8. L. M. Chin, C. W. Cheng, and R. L. Siddon, "Three-dimensional photon dose distributions with and without lung corrections for tangential breast intact treatments," Int J Radiat Oncol Biol Phys, Vol.17, No.6, pp.1327-1335, 1989.
  9. S. K. Moon and S. M. Youn, "A Comprehensive Dosimetric Analysis of Inverse Planned Intensity Modulated Radiation Therapy and Multistatic Fields Technique for Left Breast Radiotherapy," J Radiat Oncol, Vol.28, No.1, pp.39-49, 2010.
  10. F. Lohr, F. Heggemann, T. and Papavassiliu, "Is cardiotoxicity still an issue after breast -conserving surgery and could it be reduced by multifield IMRT?," Strahlenther Onkol, Vol.185, No.4, pp.222-230, 2009.
  11. Y. J. Kim, Y. I. Jang, Y. S. Ji, "Evaluation on Usefulness of Applying Body-fix to Four Dimensional Radiation Therapy," J. of Contents Association, Vol.13, No.10, pp.419-426, 2013.
  12. L. F. Paszat, W. J. Mackillop, and P. A. Groome, "Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries," J Clin Oncol, Vol.16, No.8, pp.2625-2631, 1998.
  13. M. W. McDonald, K. D. Godette, and E. K. Butker, "Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis," Int J Radiat Oncol Biol Phys, Vol.72, No.4, pp.1031-1040, 2008.
  14. A. Harsolia, L. Kestin, and I. Grills, "Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy," Int J Radiat Oncol Biol Phys, Vol.68, No.5, pp.1375-1380, 2007.
  15. Michael T. Milano, Louis S. Constine, and Paul Okunieff, "Normal Tissue Tolerance Dose Metrics for Radiation Therapy of Major Organs," Semin Radiat Oncol, Vol.17, No.2, pp.131-140, 2007.
  16. M. Y. Jung, Y. S. Ji, and K. R. Dong, "Hematological change in mice injected with radiosensitizer and irradiated with highdose radiation," J. of Contents Association, Vol.7, No.1, pp.1136-1140, 2009.